Urate predicts subsequent cardiac death in stroke survivors

被引:36
作者
Wong, KYK [1 ]
MacWalter, RS
Fraser, HW
Crombie, I
Ogston, SA
Struthers, AD
机构
[1] Univ Dundee, Ninewells Hosp & Med Sch, Dept Clin Pharmacol & Therapeut, Cardiovasc Res Grp, Dundee DD1 9SY, Scotland
[2] Univ Dundee, Ninewells Hosp & Med Sch, Dept Med, Stroke Studies Ctr, Dundee DD1 9SY, Scotland
关键词
urate; stroke; cardiac death;
D O I
10.1053/euhj.2001.2970
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims To test the hypothesis that urate predicts cardiac death after stroke independent of conventional risk factors of atherosclerosis, creatinine and diuretic use. Methods and Results Serum urate concentration was measured in an unselected cohort of 354 stroke survivors who were followed-up for a median of 2-8 years. Cardiac death was the primary end-point. Urate was associated with a statistically significant threefold increase in relative risk of cardiac death even after adjustment for other conventional risk factors. In the subgroup of patients who were not on diuretics, raised urate was associated with a 12-fold significant increase in relative risk of cardiac death after adjusting for renal function and other conventional risk factors. A urate concentration of greater than 0.31 mmol.l(-1) was 78% sensitive at predicting cardiac death within 5 years after stroke, but was only 54% specific. If urate exceeded 0.38 mmol.l(-1), specificity of predicting cardiac death within 5 years after stroke was 88%,. Conclusions Elevated scruin urate concentration may be used to stratify risk of future cardiac death after stroke. This appeared to be true even in stroke survivors who were not on diuretic therapy. (C), 2001 The European Society of Cardiology, Published by Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:788 / 793
页数:6
相关论文
共 31 条
[1]   When and why a water-soluble antioxidant becomes pro-oxidant during copper-induced low-density lipoprotein oxidation: a study using uric acid [J].
Bagnati, M ;
Perugini, C ;
Cau, C ;
Bordone, R ;
Albano, E ;
Bellomo, G .
BIOCHEMICAL JOURNAL, 1999, 340 :143-152
[2]   SERUM URIC-ACID AND CORONARY HEART-DISEASE [J].
BEARD, JT .
AMERICAN HEART JOURNAL, 1983, 106 (02) :397-400
[3]  
BOOGAERTS MA, 1983, THROMB HAEMOSTASIS, V50, P576
[4]  
Britten MB, 1999, CIRCULATION, V100, P6
[5]   Allopurinol normalizes endothelial dysfunction in type 2 diabetics with mild hypertension [J].
Butler, R ;
Morris, AD ;
Belch, JJF ;
Hill, A ;
Struthers, AD .
HYPERTENSION, 2000, 35 (03) :746-751
[6]   Xanthine oxidase inhibition with oxypurinol improves endothelial vasodilator function in hypercholesterolemic but not in hypertensive patients [J].
Cardillo, C ;
Kilcoyne, CM ;
Cannon, RO ;
Quyyumi, AA ;
Panza, JA .
HYPERTENSION, 1997, 30 (01) :57-63
[7]   IMPROVEMENT OF CARDIAC-FUNCTION BY ALLOPURINOL IN PATIENTS UNDERGOING CARDIAC-SURGERY [J].
CASTELLI, P ;
CONDEMI, AM ;
BRAMBILLASCA, C ;
FUNDARO, P ;
BOTTA, M ;
LEMMA, M ;
VANELLI, P ;
SANTOLI, C ;
GATTI, S ;
RIVA, E .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1995, 25 (01) :119-125
[8]   Serum uric acid and risk for cardiovascular disease and death: The Framingham Heart Study [J].
Culleton, BF ;
Larson, MG ;
Kannel, WB ;
Levy, D .
ANNALS OF INTERNAL MEDICINE, 1999, 131 (01) :7-+
[9]   LONG-TERM SURVIVAL AFTER 1ST-EVER STROKE - THE OXFORDSHIRE COMMUNITY STROKE PROJECT [J].
DENNIS, MS ;
BURN, JPS ;
SANDERCOCK, PAG ;
BAMFORD, JM ;
WADE, DT ;
WARLOW, CP .
STROKE, 1993, 24 (06) :796-800
[10]   MYOCARDIAL MALONDIALDEHYDE AND URIC-ACID RELEASE AFTER SHORT-LASTING CORONARY OCCLUSIONS DURING CORONARY ANGIOPLASTY - POTENTIAL MECHANISMS FOR FREE-RADICAL GENERATION [J].
DESCHEERDER, IK ;
VANDEKRAAY, AMM ;
LAMERS, JMJ ;
KOSTER, JF ;
DEJONG, JW ;
SERRUYS, PW .
AMERICAN JOURNAL OF CARDIOLOGY, 1991, 68 (04) :392-395